EZH2 and colorectal carcinoma: The underlying mechanism involved the upregulation of p27(KIP1) by statin via inhibition of EZH2; MC-1568 further increased p27(KIP1) expression by suppressing HDAC5, resulting in an antiproliferative effect in CRC (126).